Fameglow Holdings Limited (8603) AI Stock Analysis

0 Followers

Fameglow Holdings Limited

(HKEX:8603)

Select Model

Rating:72Outperform

Price Target:HKD 34.00▼(-17.79% Downside)

Action:reiterated

Date:10/21/26

The score is driven primarily by improved financial performance (profitability recovery, growing revenue, better leverage) and strong technical momentum (price well above key moving averages with positive MACD). These positives are partially offset by a very high P/E multiple and some fundamental watch items (margin compression and weaker free-cash-flow conversion versus net income).

Positive Factors

Revenue and Profitability RecoveryThe move from losses in 2021–2022 to sustained profitability, alongside strong revenue growth through 2026, indicates a meaningful operating recovery. Positive EBIT and EBITDA and healthy TTM margins provide a stronger earnings base that can support continued investment and improve resilience over the next several quarters.

Negative Factors

Margin CompressionAlthough profitability remains positive, declining gross and operating margins suggest that expansion has come with higher costs or a less favorable business mix. If this trend persists, revenue growth may translate into slower earnings growth and reduce the company’s ability to compound profits efficiently.

Fameglow Holdings Limited (8603) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 11.71B
Dividend Yield: ―
Average Volume (3M): 779.75K
Price to Earnings (P/E): 140.9
Beta (1Y): -0.68
Revenue Growth: 35.50%
EPS Growth: 18.53%
Country: Hong Kong
Employees: 467
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Personal Products & Services

Fameglow Holdings Limited Business Overview & Revenue Model

Company Description

Fameglow Holdings Limited, an investment holding entity, offers a range of non-surgical medical aesthetic services across Hong Kong. These include energy-based procedures, which employ various devices that emit energy onto the skin's surface, and min...

Fameglow Holdings Limited Financial Statement Overview

Summary

Solid recovery and growth: revenue has increased strongly from 2023–2026 with sustained profitability and healthy TTM margins (gross ~37%, net ~9%), plus positive EBIT/EBITDA. Balance sheet leverage has improved materially versus 2021–2022. Offsetting factors are noticeable margin compression versus 2023–2025 and less-than-ideal cash conversion (TTM free cash flow ~40% of net income).

Income Statement

78Positive

Balance Sheet

70Positive

Cash Flow

74Positive

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	845.30M	589.79M	435.27M	299.36M	227.58M	179.63M
Gross Profit	337.12M	218.36M	388.81M	260.89M	78.65M	154.77M
EBITDA	214.07M	145.74M	118.79M	93.66M	67.63M	40.33M
Net Income	77.46M	54.64M	45.73M	40.75M	16.37M	-8.78M
Balance Sheet
Total Assets	456.90M	456.90M	329.81M	194.48M	208.14M	219.66M
Cash, Cash Equivalents and Short-Term Investments	135.09M	110.69M	40.62M	19.31M	19.22M	1.64M
Total Debt	119.18M	119.18M	92.39M	45.55M	66.38M	94.44M
Total Liabilities	249.84M	249.84M	223.72M	134.23M	188.64M	216.53M
Stockholders Equity	207.06M	207.06M	106.09M	60.25M	19.50M	3.13M
Cash Flow
Free Cash Flow	-1.95M	45.08M	30.14M	18.28M	41.87M	-9.71M
Operating Cash Flow	72.88M	113.14M	83.53M	34.80M	74.07M	24.73M
Investing Cash Flow	-32.41M	-67.94M	-35.31M	-6.91M	-32.18M	-34.45M
Financing Cash Flow	12.85M	24.87M	-26.91M	-27.80M	-24.31M	-28.02M

Fameglow Holdings Limited Technical Analysis

Technical Analysis SentimentPositive

Last Price41.36

Price Trends

50DMA28.23Positive

100DMA21.92Positive

200DMA14.43Positive

Market Momentum

MACD2.27Negative

RSI64.77Neutral

STOCH68.41Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8603, the sentiment is Positive. The current price of 41.36 is above the 20-day moving average (MA) of 34.70, above the 50-day MA of 28.23, and above the 200-day MA of 14.43, indicating a bullish trend. The MACD of 2.27 indicates Negative momentum. The RSI at 64.77 is Neutral, neither overbought nor oversold. The STOCH value of 68.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8603.

Fameglow Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

HK:8603 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:1830	77Outperform	HKD 1.87B	10.96	43.78%	9.32%	-14.68%	-13.60%
HK:8603	72Outperform	HKD 30.76B	140.89	49.08%	―	35.50%	18.53%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
HK:0922	52Neutral	HKD 202.14M	-1.74	-13.22%	17.58%	-16.99%	-326.96%
HK:2521	52Neutral	HKD 1.78B	48.42	6.47%	―	2.78%	-41.23%
HK:0919	48Neutral	HKD 67.84M	-37.50	-0.93%	―	-2.31%	66.07%
HK:8296	37Underperform	HKD 15.12M	-0.63	-17.95%	―	-26.00%	-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

HK:8603 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:8603	Fameglow Holdings Limited	41.36	38.01	1134.63%
HK:0919	Modern Healthcare Technology Holdings Limited	0.07	0.00	5.63%
HK:0922	Anxian Yuan China Holdings Limited	0.09	-0.05	-36.81%
HK:1830	Perfect Medical Health Management Limited	1.56	0.31	24.80%
HK:8296	Sino-Life Group Limited	0.16	-0.23	-59.49%
HK:2521	Shenghui Cleanness Group Holdings Limited	0.91	0.45	96.74%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 21, 2026

Fameglow Holdings Limited AI Stock Analysis